The results of univariate Cox regression analysis indicated that several factors (e.g., M0 stage (p < 0.001), primary therapy outcome (PR&CR) (p = 0.006), PSA ≥4 ng/ml (p = 0.001), and FMR1 high expression (p = 0.041 < 0.05)) were negative predictor for overall survival outcome in prostate cancer patients; however, the other six genetic factors were not shown to be significant predictors for the overall survival outcome in prostate cancer patients. This evidence concerns the gene FMR1 and prostate carcinoma.